MedPath

UNIVERSITY OF CINCINNATI

🇺🇸United States
Ownership
-
Established
1819-01-01
Employees
5.9K
Market Cap
-
Website
https://www.uc.edu/

Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)

Phase 4
Conditions
Pulmonary Sarcoidosis
Sarcoidosis
Interventions
First Posted Date
2014-07-11
Last Posted Date
2015-12-08
Lead Sponsor
University of Cincinnati
Target Recruit Count
20
Registration Number
NCT02188017
Locations
🇺🇸

University of Cincinnati, Cincinnati, Ohio, United States

Emergency Ketamine Treatment of Suicidal Ideation

Phase 2
Conditions
Suicidal Ideation
Depression
Suicidal Impulses
Interventions
Drug: Intranasal Saline Placebo
First Posted Date
2014-07-08
Last Posted Date
2016-08-05
Lead Sponsor
University of Cincinnati
Target Recruit Count
60
Registration Number
NCT02183272
Locations
🇺🇸

University of Cincinnati, Cincinnati, Ohio, United States

Pilot Study of Nicotine Nasal Spray and Varenicline on Smoking in Methadone-Maintained Patients

Phase 4
Terminated
Conditions
Cigarette Smoking
Methadone Maintenance
Interventions
First Posted Date
2014-05-26
Last Posted Date
2018-12-05
Lead Sponsor
University of Cincinnati
Target Recruit Count
7
Registration Number
NCT02147132
Locations
🇺🇸

UC Physicians Company, LLC Opioid Treatment Program, Cincinnati, Ohio, United States

Mindfulness in Mood Dysregulated Youth

Not Applicable
Completed
Conditions
Bipolar Disorder
Mood Disorder
Emotional Disturbance
Interventions
Behavioral: MBCT-C Therapy
First Posted Date
2014-04-23
Last Posted Date
2016-05-18
Lead Sponsor
University of Cincinnati
Target Recruit Count
10
Registration Number
NCT02120937
Locations
🇺🇸

University of Cincinnati, Cincinnati, Ohio, United States

Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT

Active, not recruiting
Conditions
Recurrent Adult Primary Liver Cancer
Advanced Adult Primary Liver Cancer
Liver Metastases
Localized Unresectable Adult Primary Liver Cancer
Interventions
Procedure: positron emission tomography
Procedure: computed tomography
First Posted Date
2014-04-21
Last Posted Date
2025-04-11
Lead Sponsor
University of Cincinnati
Target Recruit Count
6
Registration Number
NCT02119065
Locations
🇺🇸

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck

Phase 1
Terminated
Conditions
Head and Neck Cancer
Interventions
Radiation: Stereotactic Radiation
First Posted Date
2014-04-10
Last Posted Date
2019-11-25
Lead Sponsor
University of Cincinnati
Target Recruit Count
7
Registration Number
NCT02110992
Locations
🇺🇸

University of Cincinnati Cancer Institute, Cincinnati, Ohio, United States

Mindfulness Based Cognitive Therapy for Youth With Anxiety at Risk for Bipolar Disorder

Not Applicable
Completed
Conditions
Anxiety
Bipolar Disorder
Interventions
Behavioral: MBCT-C
Behavioral: Waitlist Control
First Posted Date
2014-03-18
Last Posted Date
2016-05-18
Lead Sponsor
University of Cincinnati
Target Recruit Count
35
Registration Number
NCT02090595
Locations
🇺🇸

University of Cincinnati, Cincinnati, Ohio, United States

Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors

Phase 1
Completed
Conditions
Solid Tumors
Malignant Neoplasm
Interventions
First Posted Date
2014-02-26
Last Posted Date
2019-11-25
Lead Sponsor
University of Cincinnati
Target Recruit Count
24
Registration Number
NCT02071537
Locations
🇺🇸

University of Cincinnati Cancer Institute, Cincinnati, Ohio, United States

Ketamine Patient-Controlled Analgesia for Acute Pain

Phase 3
Terminated
Conditions
Acute Pain
Multiple Trauma
Fractures
Interventions
First Posted Date
2014-02-14
Last Posted Date
2017-09-21
Lead Sponsor
University of Cincinnati
Target Recruit Count
20
Registration Number
NCT02062879
Locations
🇺🇸

University of Cincinnati Medical Center, Cincinnati, Ohio, United States

Trigger Point Injections and Pelvic Rehabilitation for the Treatment of Pelvic Floor Myalgia and Sexual Pain

Phase 4
Conditions
Dyspareunia
Interventions
First Posted Date
2013-12-30
Last Posted Date
2013-12-30
Lead Sponsor
University of Cincinnati
Target Recruit Count
36
Registration Number
NCT02022722
Locations
🇺🇸

Division of Urogynecology, University of Cincinnati Medical Center, Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath